Staessen JA, Gasowski J., Wang JG et al. Risk of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials. Lancet2000;355:865-72.
2.
Leonetti G., Zanchetti A.Results of antihypertensive trials in the elderly. Am J Geriatr Cardiol2002;11:41-7.
3.
Gueyffier F. , Bulpitt C., Boissel JP et al., for the INDANA Group. Antihypertensive in the very old people: a subgroup meta-analysis of randomised controlled trials. Lancet1999;353:793-6.
4.
Wright JC, Weinstein MCGains in life expectancy from medical interventions: standardizing data and outcomes. N Engl J Med1998;339:380-5.
5.
Hennekens CHIncreasing burden of cardiovascular disease . Circulation1998;97:1095-102.
6.
Levy D., Garrison RJ, Savage DD, Kannel WB, Castelli WPLeft ventricular mass and incidence of coronary heart disease in an elderly cohort:The Framingham Heart Study. Ann Intern Med1989;110:101-07.
7.
Wei JYAge and the cardiovascular system. N Engl J Med1992;237:1735-9.
8.
Takahashi T. , Schunkert H., Isoyama S.Age-related differences in the expression of proto-oncogene and contractile protein genes response to pressure overload in the rat myocardium. J Clin Invest1992 ;89:939-46.
9.
Olivetti G. , Melissari M., Capasso JM, Anversa P.Cardiomyopathy of the aging human heart. Myocyte loss and reactive cellular hypertrophy. Circ Res1991;68:1560-8.
10.
Gardin JM, Siscovick D.,Anton-Culver H. et al. Sex, age, and disease affect echocardiographic left ventricular mass and systolic function in the free-living elderly. The cardiovascular health study. Circulation1995;91:1739-48.
11.
Olivetti G. , Giordano G., Corradi D. et al. Gender differences and aging: Effects on the human heart. J Am Coll Cardiol1995 ;26:1068-79.
12.
Ganau A., Saba PS, Roman MJ, de Simone G., Realdi G., Devereux RBAgeing induces left ventricular concentric remodelling in normotensive subjects . J Hypertens1995;13:1818-22.
13.
Niimura H., Patton KK, McKenna WJ et al. Sarcomere protein gene mutation in hypertrophic cardiomyopathy of the elderly. Circulation2002;105:446-51.
14.
DuCailar G. , Ribstein J., Daures JP, Mimran A.Sodium and left ventricular mass in untreated hypertensive and normotensive subjects. Am J Physiol1992;263:H177-81.
15.
Sundstrom J. , Lind L., Nystrom N. et al. Left ventricular concentric remodeling rather than left ventricular hypertrophy is related to the insulin resistance syndrome in elderly men. Circulation2000;101:2595-600.
16.
Roman MJ, Ganau A., Saba PS et al. Impact of arterial stiffening on left ventricular structure. Hypertension2000;36:489-94.
17.
Franklin SS , Gustin W.,Wong N. et al. Hemodynamic pattern of age-related changes in blood pressure. The Framingham Heart Study . Circulation1997;96:308-15.
18.
Blacher J.,Asmar R., Djane S., London GM, Safar MEAortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension1999;33:1111-17.
19.
Chae CU, Pfeffer MA, Glynn RJ et al. Increased pulse pressure and risk of heart failure in the elderly .JAMA1999;281:634-9.
20.
SHEP Cooperative Research Group: Prevention of Stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension.JAMA1991 ;265:3255-64.
21.
Heesen WF, Beltman FW, May JF et al. High prevalence of concentric remodeling in elderly individuals with isolated systolic hypertension from a population survey. Hypertension1997;29:539-43.
22.
Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JHRelation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med1991;114:345-52.
23.
Karam R., Lever H., Healy B.Hypertensive hypertrophic cardiomyopathy or hypertrophic cardiomyopathy with hypertension? A study of 78 patients. J Am Coll Cardiol1989;13:580-4.
24.
Krumholz HM , Larson M., Levy D.Sex differences in cardiac adaptation to isolated systolic hypertension. Am J Cardiol1993;72:310-13.
25.
DuCailar G. , Ribstein J., Pasquié JL, Halimi JM, Mimran A.Endothelial dysfunction and cardiac performance in never-treated hypertensives.Arch Mal Cœur Vaisseaux1996;89:979-82.
26.
Bikkina M., Levy D., Evans JC et al. Left ventricular mass and risk of stroke in an elderly cohort: the Framingham Heart Study. JAMA1994;272:33-6.
27.
Dahlöf B., Devereux RB, Kjeldsen SE et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet2002;359:995-1003.
28.
Staessen JA , Fagard R., Thijs L. et al. Randomized double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet1997;350:757-64.
29.
Brunner FP, Selwood HH, on behalf of the EDTA Registration Committee.Profile of patients in RRT in Europe and death rates due to major causes of death groups. Kidney Int1992;42(suppl 38):S4-S15.
30.
Powers DR, Wallin JDEnd-stage renal disease in specific ethnic and racial groups. Risk factors and benefits of antihypertensive therapy. Arch Intern Med1998;158:793-800.
31.
Walker WGHypertension-related renal injury: a major contributor to end-stage renal disease. Am J Kidney Dis1993;22:164-73.
32.
Tarnow L., Rossing P., Gall MA, Nielsen FS, Parving HHPrevalence of arterial hypertension in diabetic patients before and after the JNC-V. Diabetes Care1994;17:1247-51.
33.
Bakris GL, Williams M., Dworkin L. et al. Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group. Am J Kidney Dis2000;36:646-61.
34.
Klag MJ,Whelton PK, Randall BI et al. Blood pressure and end-stage renal disease in men. N Engl J Med1996;334:13-18.
35.
Siewert-DelleA,Ljungman S.,Andersson OK,Wilhelmsen L.Does treated primary hypertension cause end-stage renal disease? A 20-year follow-up of the Primary Prevention Study in Goteborg, Sweden. Nephrol , Dial Transplant1998;13:3034-90.
36.
Lindeman RDRenal physiology and pathology of aging. Am J Kidney Dis1990;16:275-82.
37.
Levi M., Rowe JWAging and the kidney. In: Schrier RW & Gottschalk CW (Eds.). Diseases of the Kidney. Boston, Little Brown & Co1993;2405-32.
38.
Epstein M.Aging and the kidney. J Am Soc Nephrol1996 ;7:1106-22.
39.
Davies DF, Shock NWAge changes in glomerular filtration rate, effective renal plasma flow, and tubular excretory capacity in adult males. J Clin Invest1950;29:496-507.
40.
Lindeman RD ,Tobin JD, Shock NWLongitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc1985;33:278-85.
41.
Cockroft DW , Gault MHPrediction of creatinine clearance from serum creatinine. Nephron1976;16:31-41.
42.
Feinfeld DA , Guzik H., Carvounis CP et al. Sequential changes in renal function tests in the old: Results from the Bronx longitudinal aging study. J Am Geriatr Soc1995;43:412-14.
43.
Lindeman RD , Tobin JD, Shock NWAssociation between blood pressure and the rate of decline in renal function with age. Kidney Int1984;26:861-8.
44.
De Leeuw P.Renal function in the elderly: Results from the European Working Party on High Blood Pressure in the Elderly Trial. AmJMed1993;90(suppl):45-50.
45.
Savage PJ, Pressel SL, Curb JD et al. Influence of long-term low-dose diuretic-based antihypertensive therapy on glucose, lipid, uric acid, and potassium in older men and women with isolated systolic hypertension.The Systolic Hypertension in the Elderly Program. Arch Intern Med1999;158:741-51.
46.
Voyaki SM, Staessen JA, Thijs L. et al. for the Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.Follow-up of renal function in treated and untreated older patients with isolated systolic hypertension. J Hypertens2001;19:511-19.
47.
Baylis C., Corman B.The aging kidney: insights from experimental studies. J Am Soc Nephrol1998;9:699-709.
48.
Ribstein J. , DuCailar G., Mimran A.Influence of glucose tolerance on the age-associated decline in glomerular filtration rate in essential hypertension. J Hypertens2001;19:2257-64.
49.
Mänttäri M. ,Tiula E.,Alikoski T., Manninen V.Effects of hypertension and dyslipidemia on the decline in renal function. Hypertension1995;26:670-5.
50.
Ribstein J. , DuCailar G., Mimran A.Do gene polymorphisms of the renin-angiotensin system influence the age-related decline in renal function?Eur Soc Hypertens2000, Göteborg (abstr).
51.
Fliser D., Franek E., Ritz E.Renal function in the elderly: Impact of hypertension and cardiac function . Kidney Int1997;51:1196-204.
52.
Danzinger RS ,Tobin JD, Becker LC, Lakatta EE, Fleg JLThe age-associated decline in glomerular filtration in healthy normotensive volunteers. Lack of relationship to cardiovascular performance. J Am Geriatr Soc1990;38:1127-32.
53.
Schmieder RE , Schädinger H., Messerli FHAccelerated decline in renal perfusion with aging in essential hypertension. Hypertension1994;23:351-7.
54.
Hollenberg NK,Adams DF, Solomon HS, Rashid A., Abrams HL, Merrill JPSenescence and the renal vasculature in normal man. Circ Res1974;34:309-16.
Freedman BI , Iskandar SS, Appel RGThe link between hypertension and nephrosclerosis . Am J Kidney Dis1995 ;25:207-21.
57.
Tracy RE, Velez-Duran M., Heigle T., Oalmann MCTwo variants of nephrosclerosis separately related to age and blood pressure . Am J Pathol1988;131:270-82.
58.
Burchfield CM , Tracy RE, Chyou PH, Strong JPCardiovascular risk factors and hyalinization of renal arterioles at autopsy. The Honolulu Heart Program. Arterioscler Thromb Vasc Biol1997;17:760-8.
59.
Sealey JE, Blumenfeld JD, Bell GM, Pecker MS, Sommers SC, Laragh JHOn the renal basis for essential hypertension: nephron heterogeneity with discordant renin secretion and sodium excretion causing a hypertensive vasoconstrictionvolume relationship. J Hypertens1988;6:763-77.
60.
Kasiske BLRelationship between vascular disease and age-associated changes in human kidney. Kidney Int1987;31:1153-9.
61.
Diamond JR, Karnovsky MJFocal and segmental glomerulosclerosis : analogy to atherosclerosis . Kidney Int1988;33:917-24.
62.
Fried LF, Orchard TJ, Kasiske BL, for the Lipids and renal disease progression meta-analysis study group.Effect of lipid reduction on the progression of renal disease: a meta-analysis. Kidney Int2001:59;260-9.
63.
Fogo ABRenal fibrosis and the renin-angiotensin system. Adv Nephrol Necker Hosp2001;31:69-87.
64.
Neugarten J. , Gallo G., Silbiger S., Kasiske B.Glomerulosclerosis in aging humans is not influenced by gender. Am J Kidney Dis1999 ;34:884-8.
65.
Zucchelli P. , Zuccalà A.The diagnosis dilemma of hypertensive nephrosclerosis: the nephrologist's view. Am J Kidney Dis1993 ;21(suppl 2):87-91.
66.
Tracy REBlood pressure related separately to parenchymal fibrosis and vasculopathy of the kidney. Am J Kidney Dis1992;20:124-31.
67.
Thomas SE,Anderson S., Gordon KL et al. Tubulointerstitial disease in aging: evidence for underlying peritubular capillary damage, a potential role for renal ischemia. J Am Soc Nephrol1998;9:231-42.
68.
Johnson RJ, Herrera-Acosta J., Schreiner GF, Rodriguez-Iturbe B.Subtle acquired renal injury as a mechanism of salt-sensitive hypertension .NEnglJMed2002;346:913-23.
69.
McKeigue PM , Reynard JMRelation of nocturnal polyuria of the elderly to essential hypertension. Lancet2000;355:486-8.
70.
Mimran A., Ribstein J., Jover B.Aging and sodium homeostasis. Kidney Int1992 ;41(suppl 37):S107-13.
71.
Weinberger MH, Fineberg NSSodium and volume sensitivity of blood pressure. Age and pressure change overtime. Hypertension1991;18:67-71.
72.
Bigazzi R., Bianchi S., Baldari D., Sgherri G., Baldari G., Campese VMMicroalbuminura in salt-sensitive patients: a marker for renal and cardiovascular risk factors. Hypertension1994;23:195-9.
73.
Morimoto A. , Uzu T., Fujii T. et al. Sodium sensitivity and cardiovascular events in patients with essential hypertension. Lancet1997;350:1734-7.
74.
Mailloux LU , Bellucci AG, Mossey RT et al. Predictors of survival in patients undergoing dialysis. Am J Med1988;84: 855-62.
Schulman SP , Weiss JL, Becker LC et al. The effects of antihypertensive therapy on left ventricular mass in elderly patients. NEnglJMed1990;322:1350-6.
81.
Brenner B.,Taal M.Renoprotective benefits of RAS inhibition: from ACEi to angiotensin II antagonists . Kidney Int2000;57:1803-17.
82.
Van Bortel LMAB ,Struijker-Boudier HAJ, Safar MEPulse pressure, arterial stiffness, and drug treatment of hypertension. Hypertension2001;38:914-21.
83.
Voko Z., Bots ML, Hofman A. et al. J-shaped relation between blood pressure and stroke in treated hypertensives. Hypertension1999;34:1181-5.
84.
Hansson L., Zanchetti A., Carruthers SG et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet1998 ;351:1755-62.
85.
Somes GW, Pahor M., Shor RIThe role of diastolic blood pressure when treating isolated systolic hypertension . Arch Intern Med2000;159:2004-09.
86.
Whelton PK,Appel LJ, Espeland MASodium reduction in the treatment of hypertension in older persons . JAMA1998;279:839-46.
87.
Johnson AG, Nguyen TV, Davis D.Blood pressure is linked to salt intake and modulated by the angiotensinogen gene in normotensive and hypertensive elderly subjects. J Hypertens2001;19:1053-60.
88.
DuCailar G. , Ribstein J., Mimran A.Dietary sodium and target-organ damage in essential hypertension. Am J Hypertens2002 ;15:222-9.
89.
Epstein M., Hollenberg NKAge as a determinant of renal sodium conservation in normal man. J Lab Clin Med1976;87:411-17.
90.
Lipsitz LAOrthostatic hypotension in the elderly. N Engl J Med1989;321:952-7.
91.
Gottdiener JS, Yanez D., Rautaharju P. et al. Orthostatic hypotension in the elderly: contributions of impaired LV filling and altered sympathovagal balance. Am J Geriatr Cardiol2000;9:273-80.
